// App-Quantinova.ai

Filters

Biomarkers

No records found for your search

Conference Name

No records found for your search

Country

























Company

Search valid company name..

Conference Year













Drug











Disease

Medical Centers

Search valid medical center name..

Outcomes





Presenter

Search valid presenter name..

Principal Investigators

Search valid principal investigator name..

Phase










Patient Segments

Search valid patient segment..

Result



Sponsor

Search valid sponsor name..

Study ID

Search your valid Study ID..

Therapeutic Area
























45280 Abstracts

Donor outcomes in living related liver transplantation: a single centre experience

S. Farid - International Hepato-Pancreato-Biliary Association (IHPBA) , 2016

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Multivariate analysis of predictors of outcome following multi-visceral En bloc pancreatic resections

M. McPhail - International Hepato-Pancreato-Biliary Association (IHPBA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Gastrointestinal stromal tumor

N/A

Pan-European survey on laparoscopic pancreatic surgery

T. De Rooij - International Hepato-Pancreato-Biliary Association (IHPBA) , 2016

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Orthotopic liver transplantation for patients with familial amyloid polyneuropathy: a national centre experience

J. Skipworth - International Hepato-Pancreato-Biliary Association (IHPBA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Amyloidosis, transthyretin-related

N/A

Posterior superior mesenteric artery first dissection versus classical approach in pancreaticoduodenectomy: outcomes of a case-matched study

A.E. Vallance - International Hepato-Pancreato-Biliary Association (IHPBA) , 2016

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Laparoscopic versus open liver resection for hepatocellular carcinoma in a UK population: a single centre experience

E. Francone - International Hepato-Pancreato-Biliary Association (IHPBA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Liver cancer

N/A

Missed opportunity in liver transplantation: analysis of transplants set up and subsequently cancelled

M. Pitchaimuthu - International Hepato-Pancreato-Biliary Association (IHPBA) , 2016

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Treatment strategy of hepatocellular carcinoma located in right posterior section in patients with liver cirrhosi right hepatectomy vs right posterior sectionectomy- a case matched single centre experience

V.S. Yip - International Hepato-Pancreato-Biliary Association (IHPBA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Liver cancer

N/A

3000 Cases of liver trauma: UK experience of management and outcomes over nine years

J. Barrie - International Hepato-Pancreato-Biliary Association (IHPBA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Trauma

N/A

Combined hepatectomy and hepatic pedicle lymph node resection in colorectal liver metastases is justified

R. Hodgson - International Hepato-Pancreato-Biliary Association (IHPBA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Colorectal liver metastases

N/A

Analysis of unexpected non-colorectal lesional histopathology in 1252 resections for suspected CRLM

D. O'Reilly - International Hepato-Pancreato-Biliary Association (IHPBA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Colorectal liver metastases

N/A

Engineering TIMP-3 for OA therapy

L. Troeberg - Osteoarthritis Research Society International (OARSI) , 2017

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

TIMP-3 secretion inducer

Year in Review – Biomarkers

F.E. Watt - Osteoarthritis Research Society International (OARSI) , 2017

Therapeutic Area

Disease

Drug/Treatment

Musculoskeletal

Osteoarthritis

N/A

All You Need to Know About the Microbiome!

L.J. Hall - Osteoarthritis Research Society International (OARSI) , 2017

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Obesity

N/A

Year In Review – Genetics/Genomics and Epigenetics

M.J. Peffers - Osteoarthritis Research Society International (OARSI) , 2017

Therapeutic Area

Disease

Drug/Treatment

Musculoskeletal

Osteoarthritis

N/A

Functional characterisation of the osteoarthritis genetic risk locus that resides at the gene ALDH1A2, coding for the retinoic acid synthesis enzyme RALDH2, identifies rs4646636 and rs12915901 as key target SNPs

C. Shepherd - Osteoarthritis Research Society International (OARSI) , 2017

Therapeutic Area

Disease

Drug/Treatment

Musculoskeletal

Osteoarthritis

N/A

In Vivo Models of Cartilage Repair and Chondrogenesis

F. Dell'Accio - Osteoarthritis Research Society International (OARSI) , 2017

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Enhancing the Value of Pre-clinical Studies

M. Macleod - Osteoarthritis Research Society International (OARSI) , 2017

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Hydroxychloroquine in hand OA; Results of the UK hero trial

S.R. Kingsbury - Osteoarthritis Research Society International (OARSI) , 2017

Therapeutic Area

Disease

Drug/Treatment

Musculoskeletal

Rheumatoid arthritis

Hydroxychloroquine

Postnatal influence of the ciliome in the joint

C.R. Coveney - Osteoarthritis Research Society International (OARSI) , 2017

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

Tamoxifen

Copyright © 2026. QuantiNova All rights reserved